Cargando…
Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix
OBJECTIVE: To evaluate the effects of elagolix on clinically meaningful improvements in health-related quality of life (HRQOL) measured by the EHP-30 (Endometriosis Health Profile-30). METHODS: Data from two phase III trials of elagolix for moderate to severe pain associated with endometriosis were...
Autores principales: | Taylor, Hugh S., Soliman, Ahmed M., Johns, Beverly, Pokrzywinski, Robin M., Snabes, Michael, Coyne, Karin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431150/ https://www.ncbi.nlm.nih.gov/pubmed/32769633 http://dx.doi.org/10.1097/AOG.0000000000003917 |
Ejemplares similares
-
Psychometric assessment of the PROMIS Fatigue Short Form 6a in women with moderate-to-severe endometriosis-associated pain
por: Pokrzywinski, Robin, et al.
Publicado: (2020) -
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
por: Simon, James A., et al.
Publicado: (2020) -
Elagolix in the treatment of endometriosis: impact beyond pain
symptoms
por: Archer, David F., et al.
Publicado: (2020) -
Patterns of Prescription Opioid Use in Women With Endometriosis: Evaluating Prolonged Use, Daily Dose, and Concomitant Use With Benzodiazepines
por: Lamvu, Georgine, et al.
Publicado: (2019) -
Real-World Characterization of Women with Diagnosed Endometriosis Initiating Therapy with Elagolix Using a US Claims Database
por: Surrey, Eric S, et al.
Publicado: (2020)